In the experimental design, mesenchymal stem cells are obtained from adipose tissue and applied to dogs who suffer from hernia. The company, a subsidiary of DS Pharma, cooperates with J-ARM Co., Osaka.
DS Pharma Animal Health news release, April 19, 2018
Dainippon Sumitomo (DS) Pharma Animal Health starts clinical trial on stem cell therapy for dogs